← Back to Blog
Marketing Strategy

How to Price ExoMind Treatments: Pricing Strategy for Maximum Revenue

ExoMind pricing strategy — per-session vs. package, revenue per chair hour math, and financing options that maximize revenue.

O

Oriel Mor

Founder, LivForMor Media

📅 March 24, 2026
12 min read
How to Price ExoMind Treatments: Pricing Strategy for Maximum Revenue

You've invested in an ExoMind machine. You know the clinical outcomes are strong. But now you're facing a question that keeps you up at night: How much should I charge?

Pricing is not about splitting the difference between competitor rates. It's about understanding your costs, your market position, and the value you're delivering. Price too low, and you leave money on the table while undercutting the perceived value of ExoMind treatment. Price too high, and you'll hear "I can't afford that" before patients even schedule a consultation.

This post walks you through the exact pricing framework clinic owners use to maximize revenue while keeping patient acquisition strong. We'll show you the math, the benchmarks, and the decision trees you need to price confidently.

Key Takeaways

  • Most ExoMind clinics charge $600-$800 per session ($3,500-$4,800 per 6-session course), with regional variation of 20-40%.
  • The hybrid pricing model works best — offer a package discount (6 sessions at 5-10% off) plus a premium single-session rate for undecided patients.
  • ExoMind generates $1,200/hour in revenue per chair — 3.6x more than traditional TMS at $333/hour.
  • Always offer financing — CareCredit or PatientFi increases closure rates by 30-50% and makes $3,600 feel like $300/month.
  • Price at market rate from day one — underpricing to gain market share is the #1 revenue killer for new ExoMind clinics.

What Are Other ExoMind Clinics Charging in 2026?

The ExoMind market is still maturing, which means pricing varies more than you might expect. Here's what clinic owners across the U.S. are charging:

Per-Session Pricing:

  • $500–$650 per session (lower end, typically wellness clinics or high-volume, price-sensitive markets)
  • $650–$800 per session (mid-range, most common among mental health practices)
  • $800–$1,000 per session (premium positioning, major metropolitan areas, or practices with strong brand authority)

Full Course Pricing (6 Sessions):

  • $3,000–$3,500 (budget-friendly, volume-focused clinics)
  • $3,500–$4,200 (mid-market standard)
  • $4,200–$4,800 (premium positioning)

Regional Variation: Clinics in major markets (New York, Los Angeles, San Francisco, Miami) charge 20–40% higher than clinics in secondary markets. This reflects both local insurance reimbursement rates and patient ability to pay.

Practice Type Variation: Mental health practices charge more ($650–$800/session) than medical spas or wellness clinics ($500–$650/session). Chiropractic offices pricing depression treatment tend to charge mid-range ($600–$750/session).

Pro Tip: Your pricing decision should not start with "What's everyone else charging?" It should start with your break-even analysis and target margin. Benchmark pricing is a ceiling and floor, not your strategy.

Action Step: Research three ExoMind clinics in your metro area. Note their published prices. Set your price 5-10% above the average—you're positioning on quality, not price.

Should You Price Per Session or Per Package?

This is a critical decision that affects both your cash flow and patient behavior. Let's examine the trade-offs:

Per-Session Pricing

How it works: Patients pay $600–$800 per individual session and can choose to complete fewer than 6 sessions or stop after any session.

Pros:

  • Lower barrier to entry for price-sensitive patients
  • Accommodates patients who might want 3–4 sessions instead of the full protocol
  • Easier to position as "flexible"
  • You capture full revenue regardless of completion rate

Cons:

  • Patients are more likely to "pause" after session 3 or 4, reducing lifetime value
  • Inconsistent cash flow if patients don't commit to full protocol
  • No financial incentive for completion
  • Revenue per patient varies month to month

Full-Course Package Pricing

How it works: Patients pay $3,500–$4,200 upfront (or on a payment plan) for all 6 sessions. Missed sessions don't reduce the total cost.

Pros:

  • Higher lifetime value per patient
  • Predictable revenue (you know exactly what you'll collect per patient)
  • Better clinical outcomes because patients are committed to finishing
  • Aligns financial incentive with clinical best practice
  • Easier to forecast monthly revenue

Cons:

  • Higher barrier to entry ($3,500–$4,200 vs. $600–$800)
  • More refund requests if patient stops after 2–3 sessions
  • Requires stronger financing/payment plan infrastructure
  • May deter price-sensitive patients

The Hybrid Model (Recommended)

How it works: Offer a full-course package price (6 sessions for $3,600) that's 10–15% cheaper than paying per session ($600 × 6 = $3,600). Also allow one-off "consultation sessions" at $700/session for prospects still deciding.

Why it works:

  • Package price incentivizes commitment and maximizes lifetime value
  • Single-session option lowers barrier to entry for hesitant prospects
  • You still capture data from those one-off sessions, which often convert
  • Per-session overage pricing ($700) is higher than package-included pricing ($600), naturally encouraging package uptake

Pricing example for $600/session base:

  • Full 6-session course: $3,600 (saves $100 vs. per-session rate)
  • Single consultation session: $700
  • Patients completing one session often choose the package for remaining 5

This structure encourages commitment while accommodating price-sensitive decision-makers.

How Does ExoMind Pricing Compare to Traditional TMS Revenue?

This comparison is essential because many patients ask: "Why should I choose ExoMind over traditional TMS?" For a detailed analysis, see our multi-modality marketing comparison.

MetricTraditional TMSExoMindExoMind Advantage
Number of Sessions36 sessions6 sessions6x fewer appointments
Session Duration37–40 minutesUnder 30 minutes25% shorter sessions
Time Investment (Patient)18–24 weeks2–3 weeks10x faster protocol
Total Cost to Patient$6,000–$12,000$3,000–$4,80040–60% lower out-of-pocket
Clinic Revenue (Full Course)$6,000–$12,000$3,000–$4,800Lower per-patient, higher per-chair-hour

The key insight: ExoMind isn't positioned as cheaper than TMS—it's positioned as faster, more convenient, and comparable in outcomes at a lower total cost. Your value proposition is speed and convenience, not price leadership.

Clinical Outcomes Comparison:

ExoMind gets results in 2–3 weeks versus 4–6 months. This justifies your premium pricing.

What Is the Revenue-Per-Chair-Hour Math for ExoMind?

Revenue per chair hour is the metric that actually matters. ExoMind's competitive advantage isn't about total revenue per patient—it's about revenue density (how much money you make per unit of equipment time).

Traditional TMS Revenue Per Chair Hour

Assumptions:

  • 36 sessions per patient course
  • 40 minutes per session (including setup/breakdown)
  • Cost: $8,000 per patient

Calculation:

  • Total chair time per patient: 36 sessions × 40 minutes = 1,440 minutes (24 hours)
  • Revenue per chair hour: $8,000 ÷ 24 hours = $333/hour

ExoMind Revenue Per Chair Hour

Assumptions:

  • 6 sessions per patient course
  • 30 minutes per session (including setup/breakdown)
  • Cost: $3,600 per patient

Calculation:

  • Total chair time per patient: 6 sessions × 30 minutes = 180 minutes (3 hours)
  • Revenue per chair hour: $3,600 ÷ 3 hours = $1,200/hour

The Reality

ExoMind generates 3.6x the revenue per chair hour compared to traditional TMS. This means:

  • One ExoMind chair running at capacity (6 patients × 3 hours per patient per month at 2 appointments/week) generates $21,600/month
  • One TMS chair running at capacity (2 active patients × 24 hours per patient per month) generates $8,000/month

This is why ExoMind clinics can afford to offer payment plans and still be profitable. Your margins are built into the chair efficiency, not the per-patient price.

Revenue Per Chair Hour Scenarios

ScenarioSessions/MonthRevenue/MonthAnnual Chair Revenue
Conservative (Low Utilization)6 patient-protocols (12 sessions)$7,200$86,400
Moderate (50% Utilization)12 patient-protocols (24 sessions)$14,400$172,800
Aggressive (80% Utilization)20 patient-protocols (40 sessions)$24,000$288,000

Note: These calculations assume one ExoMind chair, $600/session pricing, and 6-session standard protocol.

Action Step: Calculate your own revenue per chair hour using your current pricing. If it's below $800/hour, your pricing is too low for the equipment investment.

Should You Offer Financing or Payment Plans?

Short answer: Yes. Financing is table stakes for ExoMind clinics.

Why Financing Matters

Your addressable market for ExoMind is patients with moderate-to-severe depression who:

  1. May not have insurance coverage (depression treatment often excluded)
  2. Have high deductibles ($2,500–$10,000+)
  3. Make $50,000–$150,000/year and can't afford $3,600 upfront

Financing removes the price barrier and increases closure rates by 30–50% (PatientFi Healthcare Financing Report, 2024).

Financing Options (In Order of Implementation)

1. In-House Payment Plans (Easiest)

  • $3,600 course split into 3 payments ($1,200 per payment)
  • First payment due at commitment, remaining two over 6 weeks
  • Zero interest (you eat the financing cost as a marketing expense)
  • Simple spreadsheet tracking; no third-party platform

When to use: Clinics with strong cash position and small patient volume

2. Third-Party Financing (Most Common)

  • CareCredit, PatientFi, or Prosper Healthcare
  • 0% APR for 6–12 months (patient responsibility, not you)
  • Application approved in minutes
  • 2–3% transaction fee (you pay to the lender)

Pricing with financing:

  • $3,600 course, 0% APR over 12 months = $300/month for patient
  • Psychologically easier than $3,600 upfront
  • Approval rate: 60–75% for your income range

When to use: Most clinics should implement this immediately

3. Employer Partnership Programs

  • Partner with local employers to offer ExoMind as a mental health benefit
  • Employer subsidizes 30–50% of cost
  • Patient pays remaining balance (often $1,500–$2,000)

When to use: Clinics in metro areas with strong corporate wellness budgets

Pricing with Financing

You should not discount pricing because financing is available. Instead, position it as:

(For guidance on marketing your pricing with Google Ads, see our Google Ads budget guide.)

  • "Full course: $3,600 (or $300/month with 0% APR financing)"
  • This frames the monthly cost, not the total
  • Psychological anchoring: patients see $300/month as affordable even though it's same $3,600 total

Do not offer financing discounts. If your price is $3,600, keep it $3,600. The financing platform absorbs the interest risk, not you.

Action Step: Apply for CareCredit or PatientFi merchant enrollment this week. Add "as low as $300/month" to your ExoMind service page within 48 hours.

How Do You Handle the "Too Expensive" Objection?

This objection is almost inevitable. Here's how to address it strategically.

The Reframe

When a patient says "That's expensive," they're not saying "I can't afford it." They're saying "I don't understand the value relative to the price."

Your response:

"I understand. Let me walk you through the math. Traditional TMS costs $8,000–$12,000 and takes 18–24 weeks. ExoMind is $3,600 and takes 2–3 weeks. You're paying less and getting results 10x faster. Plus, most patients use financing, so it's $300/month. What concerns you most—the total cost or the monthly payment?"

This reframe:

  • Compares value (speed, convenience, results), not price
  • Introduces financing unprompted
  • Asks a clarifying question (total vs. monthly)
  • Handles both price-sensitive and cash-flow-sensitive objections

The Insurance Conversation

Many patients expect insurance to cover depression treatment. Some ExoMind clinics have CPT codes and seek reimbursement; others don't.

If you pursue insurance billing:

  • Coding: 90834 (psychotherapy) or 90837 (extended psychotherapy) + TMS add-on codes
  • Reimbursement: $60–$200 per session depending on payer and location
  • Your patient cost: $3,600 – (6 × $100 avg reimbursement) = $2,400 to patient
  • Timeline: 30–90 days for claims processing

If you don't pursue insurance:

  • Cleaner operations, faster payment
  • You handle all price communication directly
  • Patients use financing for out-of-pocket cost
  • Positioning: "We keep costs low by staying out of insurance bureaucracy"

Recommendation: Start without insurance billing. If reimbursement becomes available from major payers, add it. Don't let insurance billing complexity delay your launch.

Competitive Positioning Against TMS

When patients compare you to traditional TMS clinics, your positioning is: (For the complete framework, see our complete ExoMind marketing guide.)

MetricYou (ExoMind)TMS ClinicYour Advantage
Speed2–3 weeks18–24 weeks10x faster
Convenience6 short visits36 lengthy visits80% fewer appointments
Cost$3,600$8,000–$12,00050–55% savings
Outcomes58% remission at 12 months30–40% responseBetter results faster

Use this framework in every sales conversation. You're not selling price; you're selling speed, convenience, and results.

What Pricing Mistakes Are Killing ExoMind Clinic Revenue?

Mistake #1: Pricing Based on "What Everyone Else Charges"

You find that three other clinics charge $650/session, so you price at $650/session. This is reactive, not strategic.

The fix: Price based on your break-even analysis and target margin (40–50% for clinical services). Benchmark data is a floor and ceiling, not your strategy.

Mistake #2: Discounting Too Aggressively for Package Deals

You offer "6 sessions for $3,000" to close deals faster. You just trained your patients to negotiate and undercut your value.

The fix: If your per-session price is $600, your 6-session package should be $3,480–$3,600 (5–10% discount). Don't discount more than 10%.

Mistake #3: Offering Financing Without Understanding Your Margin

You offer 0% APR financing but price ExoMind at $3,000 total, thinking this helps low-income patients. You're operating at breakeven or a loss.

The fix: Price at $3,600+, offer 0% APR financing at no cost to the patient. Your margin covers the financing cost.

Mistake #4: Not Accounting for No-Shows and Cancellations

You assume 100% completion rate (6/6 sessions per patient). Realistically, 15–25% of patients complete fewer than 6 sessions.

The fix: Calculate revenue based on 4.5–5 sessions per patient average. Price accordingly so your margins survive incomplete protocols.

Mistake #5: Positioning Price Instead of Value

Your marketing says "Only $600/session" instead of "Results in 2–3 weeks at half the cost of traditional TMS."

The fix: Lead with speed and outcomes. Price is a feature, not the selling point.

Mistake #6: Changing Prices Too Frequently

You adjust pricing every quarter based on demand. Patients notice, and you lose trust and brand consistency.

The fix: Set prices annually, not quarterly. Change prices only when costs significantly change or market shifts materially.

Mistake #7: Underpricing in Your First Year

You launch at $500/session to "gain market share." A year later, your competitors charge $650–$750, and you can't raise prices without losing patients.

The fix: Price at market rate from day one. Compete on marketing and patient experience, not price. It's easier to maintain a price than to raise one.

Action Step: Lock your ExoMind pricing for 12 months starting today. Print it, post it in the office, and stop second-guessing. Compete on marketing and experience, not price.

Frequently Asked Questions

O

About the Author

Oriel Mor

Founder of LivForMor Media — a growth marketing agency that works exclusively with ketamine, TMS, and Spravato clinics. We build conversion-optimized systems that turn inquiries into booked patients.

This article was last reviewed in February 2026. Ketamine therapy marketing regulations vary by state. Always consult with a healthcare compliance attorney regarding advertising claims for ketamine and esketamine therapies.